권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
결과 내 검색
동의어 포함
Background: Diabetic peripheral neuropathy (DPN) represents a prevalent complication associated with diabetesmellitus, characterized by progressive nerve degeneration that leads to chronic pain and sensory dysfunction.
Existing treatment options are inadequate in addressing the multifaceted underlying mechanisms of DPN,underscoring the necessity for the development of novel multitarget therapeutic strategies.
Methods: A systematic evaluation explored Panax ginseng’s (GS) therapeutic efficacy using a multidisciplinaryapproach, administering the extract to diabetic rats for nerve assessments and conducting in vitro tests onSchwann cells and ND7/23 neuron cells under high glucose. Network pharmacology and molecular dockingidentified key targets and pathways, validated through experiments on mitochondrial function, oxidative stress,inflammation, and apoptosis.
Results: Administration of GS significantly improved motor nerve conduction velocity, increased pain thresholds,and restored myelination in DPN rats. In vitro, GS enhanced RSC96 and ND7/23 cell viability and migration.
Network pharmacology indicated GS modulates RAGE/NF-κB and Nrf2/PPARγ pathways, reducing oxidativestress, enhancing mitochondrial function, and lowering inflammatory cytokines. It also normalizes the Bcl2/Baxratio to mitigate apoptosis.
Conclusion: The findings of this study illustrate that GS mitigates DPN through a synergistic modulation ofmitochondrial function, oxidative stress, neuroinflammation, and apoptosis pathways, with particularly significanteffects on maintaining Schwann cell and Neuron cell functionality. Our results provide mechanistic insightsthat advocate for the repurposing of whole GS extract as a multitarget therapeutic agent for managing diabeticcomplications.*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: / 서가번호:
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.